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Abstract
Mechanisms governing secretion of proteins underlie the biologic activities and functions of
human eosinophils, leukocytes of the innate immune system, involved in allergic, inflammatory,
and immunoregulatory responses. In response to varied stimuli, eosinophils are recruited from the
circulation into inflammatory foci, where they modulate immune responses through the release of
granule-derived products. Transmission electron microscopy (TEM) is the only technique that can
clearly identify and distinguish between different modes of cell secretion. In this review, we
highlight the advances in understanding mechanisms of eosinophil secretion, based on TEM
findings, that have been made over the past years and that have provided unprecedented insights
into the functional capabilities of these cells.
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Introduction
Since the pioneer works of Palade and collaborators (Jamieson & Palade, 1967; Zetterstrom,
2006), which used electron microscopy to characterize, for the first time, organelles and
interactions between various compartments of secretory pathways, cell secretion studies
have greatly contributed to our understanding of physiological and pathological events. In
cells from the human immune system such as eosinophils, mechanisms governing secretion
underlie different biologic activities and responses to allergic and inflammatory diseases
(reviewed in Moqbel & Coughlin, 2006; Melo et al., 2008c).
Eosinophil responses involve secretion of distinct cationic proteins and numerous cytokines
with multiple functional activities (reviewed in Gleich, 2000; Adamko et al., 2005; Hogan et
al., 2008). These mediators are released in a tightly orchestrated manner to regulate the
progression of an immune response. Different from other immune cells, such as most
lymphocytes that must exclusively synthesize proteins prior to secretion, both cationic
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proteins and cytokines are additionally stored as preformed pools within eosinophil
secretory granules (Spencer et al., 2009).
Eosinophils are able to release numerous proteins from their cytoplasmic granules through
different secretion modes: (1) classical granule exocytosis by which granules release their
entire contents following granule fusion with the plasma membrane, including compound
exocytosis, which also involves intracellular granule-granule fusion before extracellular
release; (2) piecemeal degranulation, a process for secretion from intracellular granules
mediated by transport vesicles; and (3) cytolysis, which involves the extracellular deposition
of intact granules upon lysis of the cell (reviewed in Erjefalt & Persson, 2000; Moqbel &
Coughlin, 2006).
Developments in light microscopy, in particular in confocal microscopy, have provided
significant information on intracellular membrane trafficking and secretion. However,
transmission electron microscopy (TEM) is the only technique with resolution sufficient to
clearly identify and distinguish between different modes of cell secretion. We have been
using TEM to understand secretion mechanisms in human eosinophils during different
situations (Melo et al., 2005a, 2005b, 2005c, 2009; Spencer et al., 2006). Conventional TEM
in conjunction with immunonanogold EM and electron tomography has helped to elucidate
the structural organization of eosinophil secretory organelles and to identify a distinct
vesicular system, including large tubular carriers, actively involved in intracellular
trafficking and secretion of specific proteins from secretory granules (reviewed in Melo et
al., 2008a, 2008c). In this review, we highlight the advances in understanding mechanisms
of eosinophil secretion, based on TEM findings, that have been made over the past years and
that have provided unprecedented insights into the functional capabilities of these cells.
A Novel View of Eosinophil Secretory Granules: From Storage Stations to
Compartmentalized Highly Active Organelles
The secretory (also termed specific, crystalline, or secondary) granules of eosinophils are
notable not only for their ultrastructural morphology but also because they store a large
number of preformed proteins. These cytoplasmic granules are classically known by the
presence of a central crystalline core and an outer matrix surrounded by a delimiting
trilaminar membrane (Fig. 1A). Because of their unique morphology, this granule
population defines the eosinophil lineage in multiple species (Dvorak & Weller, 2000).
The presence of membranes within secretory granules of eosinophils was noted only
occasionally in prior years from allergic subjects (Okuda et al., 1981), Crohn’s disease
patients (Dvorak et al., 1980), and in platelet activating factor (PAF)-stimulated human
eosinophils (Kroegel et al., 1993). More recently, by using conventional EM to study
agonist-elicited granule emptying during eosinophil secretion (piecemeal degranulation), we
demonstrated that secretory granules indeed contain internal membranes (Melo et al.,
2005a). Notably, as secretory granule content was mobilized in activated eosinophils, as
seen after 1 h of stimulation, an extensive network of tubules and vesicles was revealed
within emptying granules, mainly in the matrix area (Fig. 2). The internal tubular network
was imaged as an elaborate system of convoluted tubules or individual tubular profiles at
times, associated with small, round, or sac-like vesicle profiles. Quantitative EM analyses
demonstrated that, in parallel with a significant increase of emptying granule numbers, there
were significant increases in numbers of granules showing internal membrane domains in
response to classical eosinophil agonists: CCL11 (eotaxin), CCL5 (RANTES), and PAF.
Moreover, membranous subcompartments, frequently seen delimiting electron dense granule
products, were prominent in granules with mobilized contents, and/or were in contact with
the inner surface of the granule membrane (Melo et al., 2005a).
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The presence within granules of membrane domains was confirmed by immunonanogold
labeling for CD63 (Fig. 3A), a tetraspanin membrane protein (Melo et al., 2005a). CD63
was localized to the granule limiting membranes, as well as to the granule matrices (Fig. 3A)
and tubular vesicles (Fig. 3Ai,Aii) (Melo et al., 2005a).
To obtain greater insights into the structural mechanisms related to mobilization of
intragranular products, eosinophils were studied by automated electron tomography (Melo et
al., 2005a). While conventional TEM studies are usually performed on ~80-nm-thick
sections, the tomographic slices are only ~4 nm thick and offer a significant advantage over
typical serial “thin sections” for tracking cell structures in three dimensions (3D).
Tomographic reconstructions revealed that mobilized eosinophil granule contents are
rearranged within intragranular vesiculotubular compartments. Intragranular membranous
subcompartments were imaged in 3D models as an aggregate of flattened tubular networks
and tubules, with interconnections in some planes (Fig. 3B,C). Structural connections were
revealed between the intragranular membranous network and the granule limiting
membrane. This may represent membrane sites involved in granule product translocation.
Intragranular structures appearing as round profiles in single routine 80-nm sections of
eosinophils were revealed by the 3D models to result from cross sections of intragranular
tubules rather than vesicles (Melo et al., 2005a).
Altogether, these findings suggest that proteins can be sorted within granule
subcompartments before reaching the outer granule membrane in order to be delivered to the
cell surface. Structural connections between the intragranular membranous network and
granule limiting membrane, as visualized by electron tomography, may further contribute to
the mobilization of granule proteins for their release into vesicles derived from granule
surfaces. Thus, EM studies provided strong evidence for sequestration and translocation of
products within eosinophil granules. A functional implication of this finding is that it adds
support to the occurrence of selective release of products from eosinophils, as documented
previously by us (Bandeira-Melo et al., 2001, 2003) and other groups (Lacy et al., 1999). It
is now well established that differential release of cytokines occurs in response to specific
stimuli (Spencer et al., 2009), and the sorting of proteins into intragranular compartments
makes them easier to be delivered to cell surface through a vesicular transport.
Imaging New Transport Carriers during Immune Responses
Large Transport Vesicles for Cell Secretion
In activated eosinophils, vesicle-mediated transport of proteins from secretory granules is
largely described both in vitro and in vivo during different conditions. Since the early
description of this secretory pathway between the eosinophil cytoplasmic granules and cell
membrane, it was believed that proteins were carried out only by small round vesicles
(Dvorak et al., 1991; Dvorak, 1992; Beil et al., 1993). Only recently has light been shed on
other subcellular compartments and mechanisms involved in secretion of eosinophil
products. EM studies have brought conclusive evidence for the participation of
morphologically distinct, large membrane-bound tubular compartments, referred to as
eosinophil sombrero vesicles (EoSVs), in the eosinophil secretory route (Spencer et al.,
2006; Melo et al., 2008c, 2009).
EoSVs, previously reported as microgranules (reviewed in Dvorak & Weller, 2000) or cup-
shaped structures (Komiyama & Spicer, 1975) in the early eosinophil literature, represent a
distinct vesicle population. They present a morphology that resembles a “mexican hat”
(sombrero) when seen in conventional cross-thin sections (Figs. 2, 3Ai). EoSVs have a
central area of cytoplasm and a brim of circular membrane-delimited vesicle. These tubular
vesicles also exhibit a “C”-shaped morphology (Fig. 3Aii). Because of this particular
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morphology and large size (~150–300 nm diameter), EoSVs are easily identified by TEM in
the cytoplasm of human eosinophils (reviewed in Melo et al., 2008a, 2008c) (Figs. 1, 2, 3A).
Quantitative EM studies showed that EoSVs are formed upon cell activation with eosinophil
agonists such as eotaxin, RANTES, and PAF, and that these large carriers were associated
with granules undergoing content release (Melo et al., 2005b). Stem cell factor (SCF), a
cytokine that is also able to activate and induce degranulation in eosinophils (Oliveira et al.,
2002), directs formation of EoSVs in both blood and tissue human eosinophils. Moreover, in
a recent EM study, we demonstrated that the total numbers of EoSVs are significantly
increased within eosinophils from a patient with hypereosinophilic syndrome (HES)(Melo et
al., 2009). Eosinophils from HES individuals are typically activated (Ackerman & Bochner,
2007), compared to cells from normal donors.
Another interesting finding revealed by TEM was the fact that EoSV formation can be
inhibited by brefeldin-A (BFA) (Melo et al., 2005b), a potential inhibitor of vesicular
transport (Nebenfuhr et al., 2002). Studies using treatment with BFA showed that not only
the total number of cytoplasmic EoSVs was reduced in the eosinophil cytoplasm, but also
membranes were clearly collapsed within secretory granules (Melo et al., 2005a, 2005b).
This observation pointed to a possible origin for EoSVs from secretory granules. In fact,
these tubular vesicles are frequently seen attached and apparently budding from specific
granules in stimulated eosinophils. A quantitative EM study showed that 90% of these
granule-attached EoSVs were associated with granules showing ultrastructural changes
typical of piecemeal degranulation, i.e., granules with lucent areas in their cores, matrices or
both, reduced electron density, disassembled matrices and cores, residual cores, or
membrane empty chambers (reviewed in Melo et al., 2008b, 2008c; Melo & Weller, 2010).
We have investigated the intriguing structure of EoSVs by electron tomography (Melo et al.,
2005b). The 3D perspective that electron tomography provides revealed that EoSVs
represent a dynamic system with a remarkable ability to change their shape and to interact
with secretory granules (Melo et al., 2005b) (Fig. 4A). These vesicles present substantial
membrane surfaces and are larger (150–300 nm in diameter) and more pleiomorphic than
the small, spherical vesicles (~50 nm in diameter) classically involved in intracellular
transport (Melo et al., 2005b, 2008c). Along the length of EoSVs, continuous, fully
connected, and cylindrical and circumferential domains were identified as well as
incompletely connected and only partially circumferential curved domains (reviewed in
Melo et al., 2008c) (Fig. 4D,E). These two domains explain both the “C” shaped
morphology of these vesicles and the presence of elongated tubular profiles very close to
typical EoSV, as frequently seen in two-dimensional cross-sectional images of eosinophils
(Melo et al., 2008c) (Figs. 1, 3Aii).
Electron tomography was also used as a tool to ascertain budding of EoSVs from secretory
granules (Melo et al., 2005a). Tracking of vesicle formation by this technique revealed that
EoSVs can indeed emerge from mobilized granules through a tubulation process (Melo et
al., 2005b) (Fig. 4A–C). This finding can explain the presence of these vesicles attached to
and/or surrounding secretory granules, mainly granules undergoing release of their contents
(Melo et al., 2008c) (Fig. 1).
Consistent with the findings in human eosinophils, EM studies have been helping to
elucidate the intrinsic complexity of transport carriers in different cell secretory pathways.
Large carriers, identified as vesiculotubular structures of complex plasticity, have been
documented in the transport system between the endoplasmic reticulum and Golgi complex,
from the endosomal system or the trans-Golgi network (TGN) to the plasma membrane, and
along axons. These large vesiculotubular carriers can be advantageous to accommodate and
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export large macromolecular cargo (reviewed in Luini et al., 2005; Watson & Stephens,
2005) and can provide an additional mechanism to transport material rapidly between
membranes in different secretory pathways (Melo et al., 2005b; Simpson et al., 2006).
Ultrastructural Immunolocalization of Granule-Stored Proteins at Transport Vesicles
As noted, degranulation in human eosinophils is the mechanism by which these cells exert
their inflammatory and immunoregulatory actions (Armengot et al., 2009; Weller et al.,
2009), and piecemeal degranulation is the most frequently encountered degranulation mode
in eosinophils from subjects with a range of inflammatory and allergic disorders (Dvorak et
al., 1980; Karawajczyk et al., 2000; Erjefalt et al., 2001; Ahlstrom-Emanuelsson et al.,
2004).
Because a vesicular traffic from secretory granules underlies piecemeal degranulation in
different cell types, a challenge to understand this secretory pathway in more detail has been
the identification of typically granule-derived products at transport vesicles. Although
numerous products are known to be localized within the eosinophil secretory granules for
decades, the ultrastructural immunolocalization of granule-stored proteins at transport
vesicles was consistently documented only during the last 5 years (Melo et al., 2005a,
2005b, 2008c, 2009).
By using a pre-embedding immunolabeling approach that is performed before standard EM
processing, we have identified consistent secretory vesicle traffic of granule-stored proteins
from eosinophil specific granules to cell membrane (Melo et al., 2005b, 2009). Pre-
embedding immuno-EM optimizes antigen preservation and is more sensitive to detect small
molecules than post-embedding labeling that is done after conventional EM processing.
Moreover, to reach antigens at membrane microdomains such as vesicles, we used Fab-
fragments linked to very small (1.4-nm) gold particles as secondary antibodies. This strategy
has enabled the identification of vesicular trafficking of typical granule-stored proteins such
as major basic protein (MBP) (Fig. 4F) and IL-4 (Fig. 4G) (Melo et al., 2005b, 2009),
recognized for a long time only within cores of eosinophil granules (Moqbel et al., 1995;
Moller et al., 1996). This vesicle-mediated secretion from secretory granules has likely been
previously underestimated because of technical issues—inadequate preservation of vesicles
and/or inability of antibodies access to them.
Immunogold EM studies have shown that both small round vesicles and EoSVs
compartments are positively immunolabeled for typical eosinophil granule products (Melo
et al., 2005a, 2005b, 2009). The identification of granule-derived products at large transport
carriers as revealed by EM adds support to a broader role for these large carriers in the
intracellular trafficking and release of cytokines and other mediators from the immune
system. In fact, while the functions of a number of cytokines and chemokines are well
known, the intracellular pathways that lead to their secretion by different cells are only now
beginning to emerge (Moqbel & Coughlin, 2006; Stow et al., 2009). Immuno-EM studies
have identified, for example, that the pro-inflammatory cytokines interleukin-6 (IL-6) and
tumor necrosis factor-alpha (TNF-α) are loaded into large vesiculotubular structures
budding from the TGN in activated macrophages (Manderson et al., 2007).
In human eosinophils, the recent EM identification of large vesicular structures as
extragranular pools of MBP, even within unstimulated cells, provides new insights into the
complex task of protein secretion during immune responses (Melo et al., 2009). These
extragranular sites appear to be relevant for the rapid release of small concentrations of
MBP under cell activation without immediate disarrangement of the intricate crystalline
cores within eosinophil specific granules. This is important because it may underlie
eosinophil functions as an immunoregulatory cell. In fact, the eosinophil functions as a
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regulator of local immune and inflammatory responses has increasingly been appreciated
(Akuthota et al., 2008); and MBP, in addition to being a recognized molecule for defense
against parasites, seems to be involved in the regulation of cytokine responses (Specht et al.,
2006). Deposition of MBP is demonstrated in affected tissues of patients with HES (Tai et
al., 1987) and other diseases, and vesicular trafficking is likely involved in this secretory
mechanism (Melo et al., 2009).
Identification of Intracellular Pools of Cytokine Receptors—Insights from
Electron Microscopy
Considering that a key function of eosinophils, as other cells from the immune system, is to
secrete a range of cytokines and other mediators, a regulatory system must ensure the
specific and timed release of these proteins. As highlighted before, eosinophils have an
additional feature compared to most cells from the immune system, i.e., their stores of
cytokines exist as preformed pools compacted within cytoplasmic secretory granules.
Therefore, upon cell stimulation, specific cytokines must be selectively mobilized from
among several dozen other preformed, granule-stored proteins, into transport vesicles. How
do eosinophils orchestrate the release of cytokines during inflammatory and allergic
responses?
The mechanisms that sort specific cytokines and other mediators into transport vesicles from
secretory granules to the cell surface are beginning to be delineated. Immuno-EM studies on
vesicular trafficking of granule-stored cytokines, such as IL-4 (Melo et al., 2005b) and
transforming growth factor-alpha (TGF-α) (Egesten et al., 1996), clearly demonstrated a
consistent and preferential labeling for these cytokines on vesicle membranes (Fig. 4G) and
not on their internal content as observed for MBP (Fig. 4F) (Melo et al., 2005a). Thus, the
hypothesis was generated that specific membrane-associated carriers participate in the
selective mobilization and trafficking of cytokines into and through vesicular compartments
within human eosinophils. In fact, intracellular granule-associated pools of cytokine receptor
chains quantitatively exceed that expressed on the cell surface. Moreover, a combination of
immuno-EM and molecular approaches demonstrated, for the first time, eotaxin-induced
association of IL-4Rα chains with intragranular membrane reorganization, preceded by
mobilization of IL-4Rα, bearing bound IL-4, from eosinophil granules into secretory
vesicles (Spencer et al., 2006).
Intracellular stores of CCR-3 and IL-6Ra were also expressed within human eosinophils,
and intracellular detection of the former increased upon stimulus-induced release of
RANTES, a known CCR-3 ligand (Spencer et al., 2006).
Altogether, these studies provide new insights into the intracellular mechanisms mediating
secretion of eosinophil granule-derived proteins. This is important to understand the
pathological basis of allergic and other eosinophil-associated inflammatory diseases.
Concluding Remarks
A key function of human eosinophils is to secrete a diversity of cytokines and other
mediators during immune responses. Electron microscopy, including electron tomography,
has provided important insights into the mechanisms of eosinophil secretion. EM studies
revealed new capacities for eosinophil secretory granules as organelles involved in sorting
of mediators for more selective loading into carriers (Melo et al., 2005a). These granules
have organized internal, CD63-positive membranes and are able to orchestrate the release of
their complex preformed array of proteins. Release of granule-stored mediators involves the
participation of an active transport vesicular system from cytoplasmic granules to the cell
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surface. Large vesiculotubular structures with remarkable plasticity were identified by EM
as active carriers of granule-stored products (Melo et al., 2008b, 2008c, 2009). These
transporters, termed EoSVs, are formed under cell activation and facilitate secretion of
eosinophil cytokines through a receptor-mediated mechanism (Spencer et al., 2006).
Another major EM revelation was that EoSVs can originate from secretory granules,
highlighting the importance of this unconventional secretory pathway for differential
secretion of cytokines during inflammatory and immunoregulatory responses (Melo et al.,
2005b). In summary, electron microscopy has been essential to understand secretory
pathways that enable cells to control the release of cytokines and other inflammatory
mediators into their environment, contributing to the understanding of immune responses
and processes underlying diseases.
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Figure 1. (Color online) Ultrastructure of activated human eosinophils
A: After stimulation with an eosinophil agonist (eotaxin), secretory granules (Gr) exhibit
different degrees of emptying of their contents and show morphological diversity indicative
of piecemeal degranulation. These granules show disassembled matrices and cores or
residual cores or lucent areas in their cores, matrices, or both. Emptying granules are
generally larger than resting granules (*), which show typical morphology with a
welldefined electron-dense crystalline core. The boxed area shows many profiles of small
and large vesicles (EoSVs, highlighted in pink in Ai) in contact and surrounding mobilized
secretory granules. Lipid bodies (LB), inflammation-related organelles (Melo et al., 2006),
are also formed in response to eotaxin stimulation. Cells were incubated with eotaxin for 1
h, immediately fixed and prepared for TEM as before (Melo et al., 2005a). N, nucleus. Bar:
(A) 1.0 μm; (Ai) 600 nm.
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Figure 2. (Color online) Secretory granules exhibit internal membranous domains in human
eosinophils
A: High magnification of an emptying granule (Gr) with internal membranous tubules
(highlighted in blue in Ai) seen in conjunction with mobilized core. EoSVs around the
granule are indicated by arrows. A budding vesicle is indicated (arrowhead). Cells were
stimulated with eotaxin as before (Melo et al., 2005a) and processed for TEM. Bar, 500 nm.
Reprinted from Melo et al. (2005a) with permission.
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Figure 3. Secretory granules are highly labeled for CD63 and show membranes organized as a
tubular network
A: Immunonanogold electron microscopy revealed pools of CD63 within specific granules
undergoing depletion of their contents. The boxed areas show different profiles of tubular
vesicles (EoSVs highlighted in pink in higher magnification in Ai and Aii) exhibiting
membrane-associated labeling for CD63. Labeling for this tetraspanin is also observed at
cell surface (arrows). B, C: Show 3D models generated from serial tomographic slices (~4
nm thick) obtained from a stimulated eosinophil secretory granule analyzed by automated
electron tomography (Melo et al., 2005a). The outer granule membrane is partially traced in
red and intragranular vesiculotubular membranes in blue. Bar: (A) 600 nm; (Ai, Aii) 300
nm; (B) 400 nm; (C) 150 nm. Panels B and C were reprinted from Melo et al. (2005a) with
permission.
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Figure 4. EoSVs are formed from mobilized secretory granules in activated eosinophils
A–C: Representative serial tomographic slices (4 nm thick) obtained from electron
tomography of a mobilized granule show substantial changes associated with EoSV
formation. EoSVs, the lumens of which are highlighted in pink in panels Ai–Ci are imaged
as open, tubular-shaped structures. Numbers on the lower right corners of the panels indicate
slice numbers through the tomographic volume. D, E: 3D models, based on electron
tomographic slices, show the structural organization of EoSVs (colored in pink). D: The
granule limiting membrane is highlighted in blue and intragranular membranes in green. E:
The model shows the corresponding boxed area in panel Ci. F, G: Immunonanogold EM for
major basic protein (F) and interleukin-4 (G) reveals labeling at EoSV lumen and
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membranes, respectively. Note that the MBP-positive EoSV is fused with the plasma
membrane (arrow) in panel F. Cells were stimulated with eotaxin as described (Melo et al.,
2005b). Gr, secretory granule. Bars: (A–C) 500 nm; (D) 800 nm; (E) 150 nm; (F, G) 200
nm. Figures 4A–C,E were reprinted from Melo et al. (2005b), Figure 4F from Melo et al.
(2009), and Figure 4G from Spencer et al. (2006) with permission.
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